SHARON CAMPBELL: Open Payments
NPI 1326029208 · GREENSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 14 payments from 10 companies in 2025. Trend: 2023 $218 · 2024 $243 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $49 |
| Novo Nordisk Inc | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Eton Pharmaceuticals, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Cipher Pharmaceuticals US LLC | 1 | $14 |
Products named: VOQUEZNA, GALZIN, Ozempic, TRELEGY ELLIPTA, VRAYLAR, NURTEC ODT, AREXVY, MOUNJARO.
Industry payments across KY — which companies pay providers there.
